Combined with the fact that CD147 had been shown to participate in the fibrosis progression61–63, especially the HG form58, collectively, these results strongly argue CD147 a promising target for limiting COVID-19 disease and post COVID-19 conditions. Here, BSG is linked to COVID-19.